Literature DB >> 3106010

Thyroid hormone-binding proteins in plasma facilitate uniform distribution of thyroxine within tissues: a perfused rat liver study.

C M Mendel, R A Weisiger, A L Jones, R R Cavalieri.   

Abstract

We used autoradiography to test the hypothesis that a major function of thyroid hormone-binding proteins in plasma is to ensure uniform distribution of thyroid hormones among cells of a given tissue. The distribution of [125I]T4 within rat hepatic lobules was determined after its single pass perfusion through the portal vein in solutions containing or lacking thyroid hormone-binding proteins. These proteins included thyroid hormone-binding globulin, thyroid hormone-binding prealbumin, and albumin. In the absence of these proteins, virtually all of the perfused T4 was taken up by the periportal cells, and subsequent perfusion with protein-free solution did not cause redistribution of this T4. In the presence of these proteins, in contrast, the perfused T4 was taken up uniformly by all cells within the lobule. Albumin alone was sufficient to ensure uniform cellular uptake of T4. However, variation of oleic acid concentrations within the physiological range markedly influenced the concentration of free T4 in a solution of 4% human serum albumin, but not in human serum. These results indicate that uniform distribution of T4 within tissues requires circulating thyroid hormone-binding proteins, and that the specific binding proteins, thyroid hormone-binding globulin and thyroid hormone-binding prealbumin, are required to ensure nonfluctuating circulating concentrations of free T4 in vivo. Other hormone-binding proteins in plasma and some transport proteins may function similarly.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106010     DOI: 10.1210/endo-120-5-1742

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

1.  Sequence of the variant thyroxine-binding globulin (TBG) in a Montreal family with partial TBG deficiency.

Authors:  O E Janssen; K Takeda; S Refetoff
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

2.  Plasma thyroxine levels in Duchenne muscular dystrophy.

Authors:  H A John
Journal:  Experientia       Date:  1990-03-15

Review 3.  Clinical recognition and evaluation of patients with inherited serum thyroid hormone-binding protein mutations.

Authors:  M S Mimoto; S Refetoff
Journal:  J Endocrinol Invest       Date:  2019-07-27       Impact factor: 4.256

4.  Thyroxine transport and distribution in Nagase analbuminemic rats.

Authors:  C M Mendel; R R Cavalieri; L A Gavin; T Pettersson; M Inoue
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 5.  Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.

Authors:  F Hervé; S Urien; E Albengres; J C Duché; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

Review 6.  Zonation of hepatic cytochrome P-450 expression and regulation.

Authors:  T Oinonen; K O Lindros
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

7.  Rapid stimulation of calcium uptake into rat liver by L-tri-iodothyronine.

Authors:  H Hummerich; S Soboll
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

8.  Delayed development of specific thyroid hormone-regulated events in transthyretin null mice.

Authors:  Julie A Monk; Natalie A Sims; Katarzyna M Dziegielewska; Roy E Weiss; Robert G Ramsay; Samantha J Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

9.  Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver.

Authors:  T Oinonen; K O Lindros
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

10.  In vivo biliary excretion and in vitro cellular accumulation of thyroxine by rats or cultured rat hepatocytes treated with a novel histamine H1-receptor antagonist.

Authors:  A Poole; D Pritchard; R B Jones; L Catto; T Leonard
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.